Inactive Instrument
Five Prime Therapeutics, Inc. Share Price
Stocks
FPRX
US33830X1046
Biotechnology & Medical Research
| 1 day | +0.03% |
| Manager | Title | Age | Since |
|---|---|---|---|
James Bradner
CEO | Chief Executive Officer | 53 | - |
Peter Griffith
DFI | Director of Finance/CFO | 67 | - |
Jonathan Graham
LAW | General Counsel | 65 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/04/21 | Issuer sale | Director | 45,000 | 0.0966% | ||
| 16/04/21 | Free | Chief Financial Officer | 5,69,947 | 1.2238% | ||
| 16/04/21 | Issuer sale | Chief Executive Officer | 5,48,971 | 1.1788% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.16% | - | - | 174.05Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.44TCr | |
| -3.11% | -2.32% | +23.28% | +77.03% | 5.93TCr | |
| +0.89% | -0.77% | +5.80% | +32.89% | 4.71TCr | |
| -0.96% | -6.11% | +26.70% | +31.24% | 4.29TCr | |
| +0.36% | +3.39% | +350.59% | +646.53% | 4.41TCr | |
| -0.20% | -0.53% | +6.84% | +99.07% | 4.08TCr | |
| -0.54% | +2.93% | +9.50% | +50.41% | 3.08TCr | |
| -2.68% | +5.11% | +33.11% | +19.50% | 2.93TCr | |
| +2.33% | -8.58% | -24.55% | +340.08% | 2.37TCr | |
| Average | +0.03% | -0.64% | +53.40% | +154.55% | 4.36TCr | |
| Weighted average by Cap. | +0.25% | -0.40% | +58.36% | +145.81% |
Employees
51
